17.09.2014 • NewsAllerganBill AckmanBotox

Allergan Special Shareholder Meeting Set for December

US drugmaker Allergan, which makes the Botox anti-wrinkle treatment, said it has reached agreement with suitors Pershing Square Capital Management and Canada's Valeant Pharmaceuticals to hold a special shareholder meeting on the originally scheduled date of Dec. 18.

The two latter companies, closely tied to investment activist shareholder Bill Ackman, also have agreed to dismiss their pending litigation before the Delaware Court of Chancery, Allergan added.

Together Pershing Square, Allergan's largest shareholder with a 9.72% stake and Valeant made a $52 billion hostile offer for Allergan in April. In August, they sued the target company, alleging it was trying to avoid a special meeting to give it time to find an alternative deal. Allergan subsequently called the meeting for the December date.

Since the initial takeover approach, Allergan has been fighting for investor support for its own standalone plan that includes cost cuts and making an acquisition of its own.

To force the company to the table, Ackman has been pushing for a special meeting where he hopes to replace most board members with his own nominees, who he expects will be more receptive to Valeant's bid.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.